Saturday 17 October 2026
Export CLVR’s income statement to Excel — free account
Clever Leaves Holdings Inc.
CLVR Healthcare Drug Manufacturers Specialty & Generic
Clever Leaves Holdings Inc.’s revenue for fiscal 2023 (year ended December 2023) was $17.4 million, up 6.14% from fiscal 2022. Revenue growth for five consecutive years, operating cash flow growth for three.
0.01
0.00
0.00%
Follow CLVR
| Dec '23 | Sep '23 | Jun '23 | Mar '23 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 2 | 3 | 5 |
+8 more TTM periods Free account |
| (55.39%) | (83.94%) | (95.59%) | (90.77%) | ||
| (42.95%) | (69.85%) | (76.41%) | (62.39%) | ||
ROIC |
(52.59%) | (46.48%) | (81.07%) | (81.85%) | |
Return on Tangible Assets |
(87.53%) | (174.63%) | (236.65%) | (201.75%) | |
Average Days of Receivables |
53.56 | 78.33 | 130.39 | 152.83 | |
Free Cash Flow per Share |
(5.53) | (7.52) | (12.07) | (17.03) | |
Free Cash Flow |
(8.68) | (11.87) | (18.03) | (24.90) | |
Capital Expenditures |
2.83 | 3.19 | 0.22 | (0.13) | |
| Other line items | |||||
Cash ROIC |
(26.83%) | (31.61%) | (44.55%) | (55.41%) | |
Accounts Receivable Turnover |
4.63 | 3.45 | 3.53 | 2.60 | |
Accounts Payable Turnover |
4.98 | 4.26 | 3.30 | 2.76 | |
Inventory Turnover |
1.69 | 0.77 | 0.75 | 0.70 | |
Average Days of Payables |
69.33 | 80.78 | 92.00 | 76.36 | |
Days of Inventory on Hand |
150.66 | 298.23 | 298.80 | 344.62 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6.55% | 8.80% | 9.63% | 9.90% | |
Selling, General and Administrative Expense of Revenue |
115.00% | 120.57% | 135.78% | 155.82% | |
Share Based Compensation of Revenue |
4.70% | 4.02% | 9.83% | 15.06% | |
Interest Coverage |
(247.52) | (3.68) | (4.20) | (15.37) | |
Operating CF/Net income |
0.64 | 0.36 | 0.32 | 0.46 | |
Depreciation/Fixed assets |
0.23 | 0.24 | 1.67 | 1.68 | |
Capex/Depreciation |
0.99 | 1.05 | 0.01 | (0.01) | |
Revenue per Share |
11.11 | 10.87 | 10.86 | 10.50 | |
Operating CF per Share |
(7.34) | (9.53) | (12.21) | (16.94) | |
Capex per Share |
1.81 | 2.02 | 0.14 | (0.09) | |
Capex to Sales |
(0.16) | (0.19) | (0.01) | 0.01 |
Columns are period end dates